References
- KearonCNatural history of venous thromboembolismCirculation200310723 Suppl 1I22I3012814982
- AndersonFAWheelerHBGoldbergRJA population-based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT studyArch Intern Med199115159339382025141
- SpencerFAEmeryCLessardDThe Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolismJ Gen Intern Med20062172272716808773
- OgerEIncidence of venous thromboembolism: a community-based study in Western France. EPI-GETBO Study Group. Groupe d’ Etude de la Thrombose de Bretagne OccidentaleThromb Haemost20008365766010823257
- GoldhaberSZBounameauxHPulmonary embolism and deep vein thrombosisLancet201237998281835184622494827
- HirschlMKundiMNew oral anticoagulants in the treatment of acute venous thromboembolism – a systematic review with indirect comparisonsVasa201443535336425147012
- SilversteinMDHeitJAMohrDNPettersonTMO’FallonWMMeltonLJ3rdTrends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based studyArch Intern Med199815865855939521222
- KearonCAklEAOrnelasJAntithrombotic therapy for VTE disease: Chest Guideline and Expert panelChest201614931535226867832
- YehCHGrossPLWeitzJIEvolving use of new oral anticoagulants for treatment of venous thromboembolismBlood201412471020102824923298
- KonstantinidesSTorbickiAAgnelliG2014 ESC guidelines on the diagnosis and management of acute pulmonary embolismEur Heart J201435433033306925173341
- The EINSTEIN InvestigatorsBauersachsRBerkowitzSDOral rivaroxaban for symptomatic venous thromboembolismN Engl J Med2010363262499251021128814
- The EINSTEIN–PE InvestigatorsBullerHRPrinsMHOral rivaroxaban for the treatment of symptomatic pulmonary embolismN Engl J Med2012366141287129722449293
- AgnelliGBullerHRCohenAOral apixaban for the treatment of acute venous thromboembolismN Engl J Med201336979980823808982
- Van EsNCoppensMSchulmanSMiddeldorpSBüllerHRDirect oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trialsBlood2014124121968197524963045
- MarvigLWangMYPrinsMHPatient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep vein thrombosisThromb Haemost2013110473274123846019
- PrinsMHMarvigLCanoSJPatient-reported treatment satisfaction with oral Rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trialThromb Res2015135228128825483215
- MarvigCLVerhoefTIde BoerAQuality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulantsThromb Res20151361697525956287
- CanoSJLampingDLMarvigLThe anticlot treatment scale in clinical trials: cross cultural validation in venous thromboembolism patientsHealth Qual Life Outcomes20121012023013426
- AtkinsonMJKumarRCappelleriJCHassSLHierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumersValue Health20058S9S2416336491
- DantasGCThompsonBVMansonJATracyCSUpshurREPatients’ perspectives on taking warfarin: qualitative study in family practiceBMC Fam Pract200451515268764
- ChevalierJde PouvourvilleGValuing EQ-5D using time trade-off in FranceEur J Health Econ201314576621935715
- Korb-SalvadelliVGillaizeauFPouchotJValidation of a French version of the 8-item Morisky medication adherence scale in hypertensive adultsJ Clin Hypertens201214429434
- PrinsMHMarrelACaritaPMultinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the ‘Perception of Anticoagulant Treatment Questionnaire’ (PACT-Q)Health Qual Life Outcomes20097919196486
- PrinsMHGuilleminIGiletHScoring and psychometric validation of the perception of anticoagulant treatment questionnaire (PACT-Q)Health Qual Life Outcomes200973019348685
- WillichSNBauersachsRGittAKTreatment satisfaction in patients with venous thromboembolism as measured with Pact-Q2: prefer in VTE RegistryValue Health2014177A496A497
- MoriskyDEAngAKrousel-WoodMWardHPredictive Validity of a Medication Adherence Measure in a Patient SettingJ Clin Hyper2008105348354
- Krousel-WoodMAIslamTWebberLSReRSMoriskyDEMuntnerPNew Medication Adherence Scale Versus Pharmacy Fill Rates in Seniors with HypertensionAm J Manag Care2009151596619146365
- MoriskyDEDiMatteoMRImproving the measurement of self-reported medication nonadherence: Final responseJ Clin Epidem201164258263
- AgenoWMantovaniLGHaasSSafety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional studyLancet Haematol201631e12e2126765643
- MacLeanSMullaSAklEAPatient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest20121412 Supple1Se23S22315262
- WangYKongMCKoYPsychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarinThromb Haemost201210878979522836920
- OliéVFuhrmanCChinFLamarche-VadelAScarabinPYde PerettiCTime trends in pulmonary embolism mortality in France, 2000–2010Thromb Res2015135233433825511577
- KneelandPFangMCCurrent issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolismPatient Prefer Adherence20104516020361065
- ShehabAElnourAABhagavathulaASNovel oral anticoagulants and the 73rd anniversary of historical WarfarinJ Saudi Heart Assoc2016281314526778903
- CastellucciLAShawJvan der SalmKSelf-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scaleThromb Res201513672773126272305
- Soliman HamadMAVan EekelenEvan AgtTvan StratenAHSelf-management program improve anticoagulation control and quality of life: a prospective randomized studyEur J Cardiothorac Surg200935226526919041254
- LubbertsBPaulino PereiraNRKabrhelCKuterDJDiGiovanniCWWhat is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysisThromb Haem20161163417431
- LancasterTRSingerDESheehanMAThe impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation InvestigatorsArch Intern Med199115110194419491929681